ACI-19626, an experimental imaging agent developed by AC Immune, may safely detect abnormal clumps of the protein TDP-43 in ...
With a simple brain scan, providers can now better detect and monitor Alzheimer’s disease. Dr. Tracy Vargas, a neurologist at ...
NEW ORLEANS (June 23, 2025)—A novel PET imaging approach has revealed distinct patterns of brain inflammation in patients with progressive apraxia of speech (PAOS), a rare neurodegenerative disorder ...
Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), is pleased to introduce ...
InvestorsHub on MSN
Radiopharm reports 90% concordance in interim results for RAD 101 brain metastases trial
Radiopharm Theranostics (NASDAQ:RADX) announced interim findings from its Phase 2b clinical trial evaluating RAD 101, an ...
Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), is pleased to announce that ...
A novel PET imaging approach can effectively quantify a key enzyme associated with brain inflammation, according to research published in the March issue of The Journal of Nuclear Medicine. The ...
PET scans can light up tumors in the body and help doctors determine if they are cancerous or benign (noncancerous). The results of a PET scan help guide medical decisions. A PET scan is a type of ...
Algernon Health (CSE:AGN, OTCQB:AGNPF, FRA:AGW0) on Wednesday announced “NovaScan Neuroimaging Clinics” as the new brand name ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results